SPAC East West Ave Acquisition files IPO

SPAC East West Ave Acquisition files for a $100 million IPO, targeting fintech, digital assets, and energy IPO Overview East West Ave Acquisition, a blank check company targeting fintech, digital assets, and energy solutions, filed on Tuesday with the SEC... Read more

Israel-based Phase 3 ocular diseases biotech Tarsier Pharma

Israel-based Phase 3 ocular diseases biotech Tarsier Pharma files for a $35 million US IPO IPO Overview Tarsier Pharma, an Israel-based Phase 3 biotech developing steroid-free therapies for ocular diseases, filed on Tuesday with the SEC to raise up to... Read more

SPAC Hall Chadwick Acquisition II files US IPO

SPAC Hall Chadwick Acquisition II files for a $265 million US IPO, targeting critical materials and infrastructure IPO Overview Hall Chadwick Acquisition II, a blank check company targeting critical materials, infrastructure, and defense, filed on Tuesday with the SEC to... Read more

8 Top SpaceX Competitors and Rivals to Watch Before Its IPO

A combination of major headlines, technological advancements and money-making opportunities has Wall Street buzzing about the space race. In particular, the imminent initial public offering of Elon Musk’s SpaceX may be the most highly anticipated IPO of the 2020s. SpaceX... Read more

SPAC Tribeca Strategic Acquisition Reduction in IPO Size

SPAC Tribeca Strategic Acquisition lowers unit offering by 20% and replaces CFO ahead of $140 million IPO IPO Overview Tribeca Strategic Acquisition, a blank check company targeting software, technology, and AI, lowered the proposed deal size for its upcoming IPO... Read more

Top 10 AI Stocks: Leading Companies in Artificial Intelligence

Artificial intelligence has understandably become one of the hottest investment trends on Wall Street. Automation and robotics is disrupting nearly every global industry. AI innovations such as OpenAI’s ChatGPT chatbot, Microsoft’s Copilot productivity tools and GitHub’s Copilot coding assistants are... Read more

SPAC JATT II Acquisition prices $60 million IPO

SPAC JATT II Acquisition prices $60 million IPO, targeting biotech and life sciences IPO Overview JATT II Acquisition, a blank check company targeting biotechs and life sciences businesses, raised $60 million by offering 6 million shares at $10. The company... Read more

Singaporean eVTOL aircraft developer Neo Aeronautics

Singaporean eVTOL aircraft developer Neo Aeronautics ups shares offered, adds insider selling ahead of $25 million US IPO IPO Overview Neo Aeronautics, a pre-revenue Singaporean developer of eVTOL and conventional aircraft, raised the proposed deal size for its upcoming IPO... Read more

Autoimmune diseases biotech Odyssey Therapeutics

Autoimmune diseases biotech Odyssey Therapeutics refiles for a $100 million IPO May 8, 2026 News Autoimmune diseases biotech Odyssey Therapeutics prices upsized IPO at $18, the high end of the range Odyssey Therapeutics, a Phase 2 biotech developing precision therapies... Read more

AI chipmaker Cerebras Systems files IPO

AI chipmaker Cerebras Systems files for an estimated $2 billion IPO May 11, 2026 News AI chipmaker Cerebras Systems ups shares, raises range to $150 to $160 ahead of $4.7 billion IPO The Sunnyvale, CA-based company now plans to raise... Read more

Geothermal energy developer Fervo Energy files IPO

Geothermal energy developer Fervo Energy files for an estimated $250 million IPO May 12, 2026 News Geothermal energy developer Fervo Energy prices upsized IPO at $27, above the upwardly revised range Fervo Energy, which is developing next-generation geothermal energy projects,... Read more

Healthcare SPAC Amanat Acquisition files IPO

Healthcare SPAC Amanat Acquisition files for a $75 million IPO IPO Overview Amanat Acquisition, a blank check company targeting biotech and life sciences, filed on Friday with the SEC to raise up to $75 million in an initial public offering.... Read more